These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1. Singh S; Hämäläinen RH Cells; 2024 Jan; 13(2):. PubMed ID: 38247861 [TBL] [Abstract][Full Text] [Related]
4. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea. Kim KH; Song JS; Park CW; Ki CS; Heo K Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618 [TBL] [Abstract][Full Text] [Related]
5. Unverricht-Lundborg disease: homozygosity for a new splicing mutation in the cystatin B gene. Pinto E; Freitas J; Duarte AJ; Ribeiro I; Ribeiro D; Lima JL; Chaves J; Amaral O Epilepsy Res; 2012 Mar; 99(1-2):187-90. PubMed ID: 22154554 [TBL] [Abstract][Full Text] [Related]
6. Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb-/- Microglia. Körber I; Katayama S; Einarsdottir E; Krjutškov K; Hakala P; Kere J; Lehesjoki AE; Joensuu T PLoS One; 2016; 11(6):e0158195. PubMed ID: 27355630 [TBL] [Abstract][Full Text] [Related]
7. Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs. Lucchino V; Scaramuzzino L; Scalise S; Lo Conte M; Zannino C; Benedetto GL; Aguglia U; Ferlazzo E; Cuda G; Parrotta EI Cells; 2022 Nov; 11(21):. PubMed ID: 36359887 [TBL] [Abstract][Full Text] [Related]
8. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations. Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931 [TBL] [Abstract][Full Text] [Related]
9. Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1. Tegelberg S; Kopra O; Joensuu T; Cooper JD; Lehesjoki AE J Neuropathol Exp Neurol; 2012 Jan; 71(1):40-53. PubMed ID: 22157618 [TBL] [Abstract][Full Text] [Related]
10. Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1. Okuneva O; Körber I; Li Z; Tian L; Joensuu T; Kopra O; Lehesjoki AE Glia; 2015 Mar; 63(3):400-11. PubMed ID: 25327891 [TBL] [Abstract][Full Text] [Related]
12. A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients. Assenza G; Benvenga A; Gennaro E; Tombini M; Campana C; Assenza F; Di Pino G; Di Lazzaro V Epilepsia; 2017 Feb; 58(2):e31-e35. PubMed ID: 27888502 [TBL] [Abstract][Full Text] [Related]
13. Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study. Bosak M; Sułek A; Łukasik M; Żak A; Słowik A; Lasek-Bal A Epilepsy Behav; 2020 Nov; 112():107439. PubMed ID: 32920378 [TBL] [Abstract][Full Text] [Related]
14. Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy. Vaarmann A; Kaasik A; Zharkovsky A Epilepsia; 2006 Oct; 47(10):1650-4. PubMed ID: 17054687 [TBL] [Abstract][Full Text] [Related]